Skip to content

Tonix Pharmaceuticals Logo

  • About
    • Leadership
      • Executive Team
      • Board of Directors
    • Facilities
    • State Disclosures
  • Therapeutic Areas Overview
    • Central Nervous System
      • Fibromyalgia
      • Migraine
    • Immunology
      • Organ Transplant Rejection
      • Gastro-Intestinal Cancers
    • Infectious Disease
      • Mpox (Monkey Pox)
      • Smallpox
  • Pipeline
    • Central Nervous System
      • TNX-102 SL
    • Immunology
      • TNX-1500
      • TNX-1700
    • Infectious Disease
      • TNX-801
      • TNX-4200 CD45
    • Expanded Access Policy
  • Medicines
  • Clinical Trials
  • News & Events
    • Press Releases
    • Tonix in the News
    • Tonix Sponsored News
    • Investor Presentations
    • Scientific Presentations
    • IR Events
    • Op-eds
  • Investors
    • News & Events
    • Presentations
      • Investor Presentations
      • Scientific Presentations
      • Program Specific Presentations
      • Conference Materials
    • Multimedia
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
  • Contact Us

State Disclosures

The following is information that may affect marketing, sales, and other activities at Tonix Medicines, Inc. In accordance with state laws, Tonix is disclosing this information in the form required.

Select Medication

  • Tonmya™ (cyclobenzaprine HCI) sublingual tablets 2.8 mg
  • Tosymra® (sumatriptan nasal spray) 10 mg
  • Zembrace® Symtouch® (sumatriptan injection) 3 mg

Tonmya™ (cyclobenzaprine HCI) sublingual tablets 2.8 mg

Tosymra® (sumatriptan nasal spray) 10 mg

California — Comprehensive Compliance Program

California — Declarations

Colorado

Vermont – Long Form

Vermont – Short Form

Zembrace® Symtouch® (sumatriptan injection) 3 mg

California — Comprehensive Compliance Program

California — Declaration

Colorado

Vermont – Long Form

Vermont – Short Form

Sign up for Email Alerts
  • Contact Us
  • Privacy Policy
  • Terms of Service
  • Site Map

© 2025 Tonix Pharmaceuticals Holding Corp.